http://www.mail.com/companies/525980-watson-pharmaceuticals-inc.html Mail.com - the best personalized free web-based Email en en http://sec-s.uicdn.com/mail.com/2.29/img/mailcom_logo_rss.png http://www.mail.com/companies/525980-watson-pharmaceuticals-inc.html http://www.mail.com/scitech/health/2157012-court-pay-to-delay-generic-drugs-illegal.html WASHINGTON (AP) — Deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can sometimes be illegal and therefore can be challenged in court, the Supreme Court said Monday. The justices voted 5-3 to allow the government to inspect and challenge what it calls... Mon, 17 Jun 2013 20:33:26 GMT http://www.mail.com/scitech/health/2157012-court-pay-to-delay-generic-drugs-illegal.html 2013-06-17T20:33:26Z http://www.mail.com/business/economy/2097592-actavis-buying-warner-chilcott-85b-deal.html NEW YORK (AP) — Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market. The announcement Monday comes after the companies said earlier this month that they were in talks about a possible pairing of one of the world's largest generic drugmak... Mon, 20 May 2013 22:36:45 GMT http://www.mail.com/business/economy/2097592-actavis-buying-warner-chilcott-85b-deal.html 2013-05-20T22:36:45Z http://www.mail.com/business/economy/2077524-actavis-warner-chilcott-discussing-combination.html NEW YORK (AP) — Drugmakers Actavis Inc. and Warner Chilcott PLC said Friday that they in early talks about a possible combination of the two companies. Both say there is no agreement on a deal yet. Shares of both companies soared in Friday trading. Actavis was formed in October through a $5.6 billion combination of Watson Pharmaceuticals of New Jersey and... Fri, 10 May 2013 22:27:35 GMT http://www.mail.com/business/economy/2077524-actavis-warner-chilcott-discussing-combination.html 2013-05-10T22:27:35Z http://www.mail.com/business/economy/1992974-health-insurers-lead-stocks-higher-wall-street.html U.S. stocks closed at a record highs Tuesday after reports on auto sales and factory orders provided the latest evidence that the U.S. economy is strengthening. Traders plowed money back into European stocks as the financial situation in Cyprus appeared to stabilize. Health insurers powered the gains a day after the government released revised reimburseme... Tue, 02 Apr 2013 23:51:37 GMT http://www.mail.com/business/economy/1992974-health-insurers-lead-stocks-higher-wall-street.html 2013-04-02T23:51:37Z http://www.mail.com/scitech/health/1977372-high-court-struggles-generic-drug-delay-deals.html WASHINGTON (AP) — Supreme Court justices appeared troubled Monday over whether to stop deals between pharmaceutical corporations and their generic drug competitors that the government says could keep cheaper forms of medicine from American consumers for longer periods of time. Justices heard arguments from the Justice Department against what the governmen... Mon, 25 Mar 2013 21:19:55 GMT http://www.mail.com/scitech/health/1977372-high-court-struggles-generic-drug-delay-deals.html 2013-03-25T21:19:55Z http://www.mail.com/scitech/health/1976398-court-drug-companies-pay-to-delay-generics.html WASHINGTON (AP) — Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines that can top 90 percent. The Obama administration, backed by ... Mon, 25 Mar 2013 03:42:57 GMT http://www.mail.com/scitech/health/1976398-court-drug-companies-pay-to-delay-generics.html 2013-03-25T03:42:57Z